Wei Xu
Director/Board Member at UGenix Biotech Ltd.
Profile
Wei Xu has held positions as a Director at AnHeart Therapeutics, Inc., a Non-Executive Director at UGenix Biotech Ltd., and a Partner at Decheng Capital LLC.
Wei Xu active positions
Companies | Position | Start |
---|---|---|
Decheng Capital LLC
Decheng Capital LLC Investment ManagersFinance Decheng Capital LLC is a venture capital firm founded by Min Cui in 2011 having headquartered at Shanghai, China. | Private Equity Investor | 01/01/2017 |
AnHeart Therapeutics, Inc.
AnHeart Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Part of Nuvation Bio, Inc., AnHeart Therapeutics, Inc. is a clinical stage biopharmaceutical company based in New York, NY. AnHeart Therapeutics is focused on developing a pipeline of novel precision oncology therapeutics for areas of significant unmet medical need. The company's lead investigational therapy, taletrectinib, is a next-generation ROS1-inhibitor currently in pivotal phase 2 trials for ROS1-positive non-small cell lung cancer (NSCLC). AnHeart Therapeutics, Inc. also has a second investigational therapy, safusidenib, being evaluated in a phase 2 trial for -mutant glioma. AnHeart Therapeutics is supported by leading life sciences investors and has built an organization with deep oncology drug discovery and development expertise. The company was founded by Bing Yan, Junyuan Jerry Wang, Lihua Zheng, and the CEO is Junyuan Jerry Wang. AnHeart Therapeutics was acquired by Nuvation Bio, Inc. on April 09, 2024 for $89.30 million. | Director/Board Member | - |
UGenix Biotech Ltd.
UGenix Biotech Ltd. Miscellaneous Commercial ServicesCommercial Services UGenix Biotech Ltd. is a holding company, which engages in the provision of prenatal testing, precision oncology, and pathogenic detection services. The company was founded on October 26, 2021 and is headquartered in Hong Kong. | Director/Board Member | 01/04/2022 |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Private companies | 3 |
---|---|
Decheng Capital LLC
Decheng Capital LLC Investment ManagersFinance Decheng Capital LLC is a venture capital firm founded by Min Cui in 2011 having headquartered at Shanghai, China. | Finance |
AnHeart Therapeutics, Inc.
AnHeart Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Part of Nuvation Bio, Inc., AnHeart Therapeutics, Inc. is a clinical stage biopharmaceutical company based in New York, NY. AnHeart Therapeutics is focused on developing a pipeline of novel precision oncology therapeutics for areas of significant unmet medical need. The company's lead investigational therapy, taletrectinib, is a next-generation ROS1-inhibitor currently in pivotal phase 2 trials for ROS1-positive non-small cell lung cancer (NSCLC). AnHeart Therapeutics, Inc. also has a second investigational therapy, safusidenib, being evaluated in a phase 2 trial for -mutant glioma. AnHeart Therapeutics is supported by leading life sciences investors and has built an organization with deep oncology drug discovery and development expertise. The company was founded by Bing Yan, Junyuan Jerry Wang, Lihua Zheng, and the CEO is Junyuan Jerry Wang. AnHeart Therapeutics was acquired by Nuvation Bio, Inc. on April 09, 2024 for $89.30 million. | Health Technology |
UGenix Biotech Ltd.
UGenix Biotech Ltd. Miscellaneous Commercial ServicesCommercial Services UGenix Biotech Ltd. is a holding company, which engages in the provision of prenatal testing, precision oncology, and pathogenic detection services. The company was founded on October 26, 2021 and is headquartered in Hong Kong. | Commercial Services |
- Stock Market
- Insiders
- Wei Xu